13F-HR filed by CHARLES SCHWAB INVESTMENT MANAGEMENT INC
CHARLES SCHWAB INVESTMENT MANAGEMENT INC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-13, with 3,546 holding rows worth $310,319,827,223.
- Accession
- 0001085146-23-001129
- Filer
- CIK 884546
- Filed
- 2023-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A combination report, 3,600 entries on the cover page, a total value of $310,319,827,223 stated on the cover page (in dollars after the unit check, H1), rows summing to $310,319,827,223 with VALUE read as dollars as filed, 13F file number 028-03128. The quarter's positions are built on this report. The resolved quarter.
Other managers
- reports for this filerAMERICAN CENTURY COMPANIES INC028-11918
- reports for this filerBAILLIE GIFFORD OVERSEAS LTD028-04395
- reports for this filerBlackRock Investment Management, LLC028-12016
- reports for this filerHARRIS ASSOCIATES L P028-02013
- reports for this filerMondrian Investment Partners LTD028-11450
- reports for this filerAriel Investments, LLC028-04003
- included managerCharles Schwab Trust Co028-19636
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BITNILE HOLDINGS INC | 09175M101 | CMN | 163,474 | $20,026 | dollars as filed | |
| ONCOCYTE CORP | 68235C107 | COM | 62,284 | $19,987 | dollars as filed | |
| ZYNERBA PHARMACEUTICALS INC | 98986X109 | COM | 37,596 | $19,926 | dollars as filed | |
| GALECTIN THERAPEUTICS INC | 363225202 | COMMON STOCK | 17,413 | $19,677 | dollars as filed | |
| FORTRESS BIOTECH INC | 34960Q109 | COM | 29,965 | $19,627 | dollars as filed | |
| Enzo Biochem Inc | 294100102 | Common Stock | 13,471 | $19,264 | dollars as filed | |
| LIPOCINE INC NEW | 53630X104 | CMN | 50,000 | $19,200 | dollars as filed | |
| SYNLOGIC INC | 87166L100 | COM | 25,000 | $19,000 | dollars as filed | |
| IZEA WORLDWIDE INC COM NEW | 46604H105 | Stock | 34,489 | $18,728 | dollars as filed | |
| BRAINSTORM CELL THERAPEUTICS | 10501E201 | COM | 11,287 | $18,511 | dollars as filed | |
| VIRACTA THERAPEUTICS INC | 92765F108 | COM | 12,430 | $18,148 | dollars as filed | |
| NAUTILUS INC | 63910B102 | COMMON STOCK | 11,457 | $17,529 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 16,549 | $17,376 | dollars as filed | |
| RED CAT HLDGS INC | 75644T100 | COM | 18,398 | $17,294 | dollars as filed | |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 29,948 | $16,621 | dollars as filed | |
| MYMD PHARMACEUTICALS INC | 62856X102 | COMMON | 13,965 | $16,060 | dollars as filed | |
| QUANTUM COMPUTING INC | 74766W108 | COM | 10,216 | $15,426 | dollars as filed | |
| RVL PHARMACEUTICALS PLC | G6S41R101 | COM | 13,322 | $14,921 | dollars as filed | |
| BOXLIGHT CORP | 103197109 | COM CL A | 46,965 | $14,597 | dollars as filed | |
| CARROLS RESTAURANT GROUP INC | 14574X104 | COM | 10,728 | $14,590 | dollars as filed | |
| LEAP THERAPEUTICS INC | 52187K101 | COM | 32,000 | $14,400 | dollars as filed | |
| NEXTCURE INC | 65343E108 | COM | 10,000 | $14,100 | dollars as filed | |
| BRIGHT GREEN CORP | 10920G100 | COM | 28,510 | $13,385 | dollars as filed | |
| ELECTROCORE INC | 28531P103 | COM | 45,528 | $11,692 | dollars as filed | |
| TRICIDA INC | 89610F101 | COM | 74,893 | $11,451 | dollars as filed | |
| CORBUS PHARMACEUTICALS HLDGS | 21833P103 | COM | 99,416 | $10,985 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 27,369 | $10,811 | dollars as filed | |
| EMCORE CORP | 290846203 | COM | 11,147 | $10,729 | dollars as filed | |
| ORAGENICS INC | 684023302 | COM PAR | 100,778 | $10,592 | dollars as filed | |
| BUZZFEED INC CL A NEW | 12430A102 | Stock | 14,995 | $10,341 | dollars as filed | |
| NATIONAL CINEMEDIA INC | 635309107 | COM | 46,329 | $10,192 | dollars as filed | |
| GELESIS HLDGS INC | 36850R204 | COM | 35,034 | $10,174 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T103 | COM | 16,238 | $9,579 | dollars as filed | |
| HEPION PHARMACEUTICALS INC | 426897104 | COM | 31,535 | $9,464 | dollars as filed | |
| SHIFT TECHNOLOGIES INC | 82452T107 | CL A | 60,782 | $9,050 | dollars as filed | |
| FINCH THERAPEUTICS GROUP INC | 31773D101 | COM | 18,783 | $9,016 | dollars as filed | |
| GREENIDGE GENERATION HLDGS I | 39531G100 | COM | 28,120 | $8,129 | dollars as filed | |
| CRYPTYDE INC | 22890A104 | COM | 40,327 | $7,731 | dollars as filed | |
| HALLMARK FINL SERVICES INC | 40624Q203 | COM | 12,358 | $7,220 | dollars as filed | |
| BIOTRICITY INC COM NEW | 09074H104 | Stock | 16,000 | $7,208 | dollars as filed | |
| CORTEXYME INC | 22053A107 | COM | 11,013 | $7,020 | dollars as filed | |
| THERIVA BIOLOGICS INC | 87164U409 | COM NEW | 13,566 | $6,170 | dollars as filed | |
| AXCELLA HEALTH INC | 05454B105 | COM | 18,250 | $5,977 | dollars as filed | |
| Ohr Pharmaceutical Inc | 64132K102 | COM | 29,716 | $5,652 | dollars as filed | |
| GREENBOX POS | 39366L208 | COM NEW | 10,419 | $4,780 | dollars as filed | |
| MEDAVAIL HOLDINGS INC | 58406B103 | COM | 11,882 | $3,562 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-23-001129 | this filing | 2023-02-13 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001085146-24-000008 | added | 2024-01-04 | acceptance time not in the bulk data set |